If your email program has trouble displaying this email, view as a webpage. Recently Posted Guidance Documents 4/28/2022 - Crohn's Disease: Developing Drugs for Treatment 4/28/2022 - Draft Guidance for Industry: The Accredited Third-Party Certification Program: Questions and Answers 4/28/2022 - Ulcerative Colitis: Developing Drugs for Treatment 4/27/2022 - Guidance for Industry: Compliance with Providing an Acceptable Unique Facility Identifier for the Foreign Supplier Verification Programs for Food Importers Regulation 4/27/2022 - Providing Submissions in Electronic Format — Postmarketing Safety Reports 4/27/2022 - Draft Guidance for Industry: Action Levels for Lead in Juice Guidance Document Search Search all FDA official guidance documents and other regulatory guidance

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA